Long-term treatment continuation of gecacitinib in myelofibrosis patients after ruxolitinib failure
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Yi Zhang, Hu Zhou, Qike Zhang, Qingchi Liu, Sujun Gao, Zhijian Xiao, Minghui Duan, Liangming Ma, Wei WANG, Huibing Dang, Guangsheng He, Hongmei Jing, Junmin Li, Haiping Yang, Huanling Zhu, Chunkang Chang, Yuqing Chen, Xin Du, Mei Hong, Xin Li, Jishi Wang, Na Xu, Peng Zhao, Shanshan Suo, Jie Jin
Institutions: First Affiliated Hospital Zhejiang University, Zhengzhou University, Henan Cancer Hospital, Gansu Provincial Hospital, Hebei Medical University, First Affiliated Hospital of Hebei Medical University, First Hospital of Jilin University, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, Shanxi Medical University, Affiliated Hospital of Qingdao University, Nanyang Medical College, Jiangsu Province Hospital, Peking University, Peking University Third Hospital, Shanghai Jiao Tong University, Ruijin Hospital, Henan University of Science and Technology, First Affiliated Hospital of Henan University of Science and Technology, Sichuan University, West China Hospital of Sichuan University, Shanghai Sixth People's Hospital, Henan Provincial People's Hospital, Guangdong Provincial People's Hospital, Huazhong University of Science and Technology, Central South University, Third Xiangya Hospital, Xiangya Hospital Central South University, Affiliated Hospital of Guizhou Medical University, Nanfang Hospital, Southern Medical University
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417023487
Cites:
Cited by:
Related to: